Trials / Completed
CompletedNCT04255368
Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response
Effect of Choline Source and Gut Microbiota Composition on Trimethylamine-N-oxide Response in Humans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Utah State University · Academic / Other
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to determine the production of trimethylamine-N-oxide (TMAO) from different forms of choline and whether this response is modified by the gut microbiota composition.
Detailed description
The overall goal of this research is to identify dietary and physiological factors contributing to elevated levels of trimethylamine-N-oxide (TMAO), a choline-derived gut-microbiome-dependent metabolite that has been identified to increase cardiovascular disease risk. Our recent findings indicate that the gut microbiome may account for variations in TMAO levels, whereby those with a greater enrichment of Firmicutes to Bacteroidetes had elevated TMAO response to dietary precursor intake. However, the interaction between choline intake and gut microbiota composition as a determinant of interindividual variations in TMAO response has not been investigated. This study sought to i) compare plasma and urinary TMAO response after acute challenge containing different forms of choline; and ii) to determine the association between differences in TMAO response with differences in gut microbiota composition. To accomplish these objectives, a randomized, controlled cross-over study was conducted in healthy participants (n=41). The study incorporated three arms comprised of study meals containing (i) 600 mg choline as choline bitartrate; (ii) 600 mg choline as phosphatidylcholine; or (iii) no choline. Each meal was served with a bagel with margarine-butter spread and one cup of water, administered in a single day and separated by a 1-week washout period. Baseline blood sample was obtained by a phlebotomist using a standard venipuncture procedure, and participants collected their baseline urine sample. They also turned in a one-time self-collected baseline stool sample. Following the consumption of the study meal, serial blood samples were collected at 30 min and 1, 2, 4 and 6 h, and urine samples collected throughout the 6 h study period. At 4.5 h, participants were provided a fixed fruit snack (i.e., 2 single serving prepackaged applesauce) and water.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Water-soluble choline | 600 mg choline as choline bitartrate |
| OTHER | Fat-soluble choline | 600 mg choline as phosphatidylcholine |
| OTHER | No choline control | No choline |
Timeline
- Start date
- 2017-11-09
- Primary completion
- 2018-06-16
- Completion
- 2020-07-25
- First posted
- 2020-02-05
- Last updated
- 2020-11-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04255368. Inclusion in this directory is not an endorsement.